NEWS & VIEWS

Global private equity and venture capital news and research

Healthcare & Life Sciences

13 April 2015

Biotech sees second month of declining investment from PE, VC firms $

venbio_sq.jpg Private equity and venture capital investment activity targeting the global biotechnology sector declined in March for the second month in a row, new research shows.

12 March 2015

Biotech PE, VC value up on 2015 despite monthly value drop $

lab petri life science clinic The value of private equity, venture capital and development capital investment targeting global biotechnology companies fell by 48 per cent in February compared to the previous month despite a year-on-year gain.

9 March 2015

Biotech VC funding largely targeting new drugs over improving existing treatments $

bio Venture capital funding of biotechnology businesses is heavily focused towards novel drug R&D rather than improving existing treatments, new research suggests.

10 February 2015

Weak start to the year for global biotech investment value $

biotech virus lab The value of private equity, venture capital and development capital investment in the global biotechnology sector decreased in January compared to the previous month despite a rise in volume. A total of $455m was invested in biotech companies over the four weeks, down 82 per cent from a high base of $2.58bn in December according to[...]

17 February 2014

Mega buyout boosts biotech private equity activity $

The value of private equity, venture capital and development capital investment targeting biotechnology companies started 2014 on an impressive note, leaping to its highest point in the last 12 months.

17 September 2013

Fundraising for life science VCs continues decline in 2013 $

Fundraising by life science venture capitalists continued to decline during 2013, with estimated fundraising for the first half of the year falling to $1.3bn, corresponding to an annualized rate of $2.6bn.

22 August 2013

Momentum builds in healthcare venture capital $

Large exits, specifically those venture capital-backed healthcare deals with at least $75m upfront in biotech and $50m upfront for medical device and services hit an eight-year high, according to a recent report.

3 April 2013

Media & technology M&A sees month-on-month boost $

A total of 336 M&A deals were announced in the media and technology space in March 2013, as strategic buyers and venture capital and growth investors stepped up their activity.

25 February 2013

US life sciences sees double digit dip in VC activity $

US venture capital funding in the life sciences sector dropped 14 per cent in dollars and seven per cent in deals during 2012, new research has found.

18 January 2013

Private equity leads push for healthcare, pharma IT deals $

Private equity firms were responsible for four of the top ten deals in the global pharma/ healthcare IT industry, as transaction volumes increased 21 per cent and deal values also increased.

Page 1 of 1612345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015